Acta Pharmaceutica Sinica B
|
2025, 15(8): 4316-4318
• Highlights •
Engineered tumor specific AAV for IL-12 delivery in ovarian cancer immunotherapy
Full
Fan Tong1,2, Hanmei Li3, Huile Gao2, Yuan Li1
Affiliations
1 Department of Obstet Gynecol, Peking University Third Hospital, Beijing 100191, China;
2 Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Chengdu 610041, China;
3 School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China
doi: 10.1016/j.apsb.2025.05.033
Outline
AAV
/
Gene therapy
/
Tumor specific delivery
/
IL-12
/
Cancer immunotherapy
Fan Tong, Hanmei Li, Huile Gao, Yuan Li.
Engineered tumor specific AAV for IL-12 delivery in ovarian cancer immunotherapy[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(8)
: 4316
-4318
.
DOI: 10.1016/j.apsb.2025.05.033
Year 2025 volume 15 Issue 8
PDF
6
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.05.033
- Receive Date:2025-05-26
- Online Date:2026-09-17